In an exclusive interview with Thiruamuthan, Assistant Editor of India Pharma Outlook, Jordan Kohlbeck, Head of Pharmaceuticals at IAG Cargo, discusses how India’s growing role as a global pharmaceutical exporter is driving transformation in the air

In an exclusive interview with Thiruamuthan, Assistant Editor at India Pharma Outlook, Ankit Gupta, President of ASPA, discusses how serialization and digital authentication are driving a paradigm shift in the pharmaceutical industry

Rehan Khan, Managing Director of MSD India, shares that India has more unicorn startups than billion-dollar drugs. Despite a huge patient pool with diabetes, hypertension, and cancer, the country has yet to deliver a homegrown therapy crossing $1 bil

The distribution was completely disregarded in this country. However, the time has come since distribution does not just imply taking the product and delivering to people in different locations.

India’s biotech and pharmaceutical R&D journey began much earlier than many believe, with its foundations laid in the 1990s and early 2000s. Indian companies, inspired by global multinationals such as Pfizer, Merck, and Novartis, invested heavily in

Today, ensuring innovation remains accessible is paramount. We are now able to deliver therapies like CAR-T at 5–8% of the cost compared to the U.S., without compromising on quality or outcomes. Currently, India’s strategic investments in local manuf